Skip to main content
Clinical Trials/NCT00599586
NCT00599586
Completed
Not Applicable

Randomized Controlled Trial of Treating Migraine With Acupuncture

Chengdu University of Traditional Chinese Medicine1 site in 1 country480 target enrollmentNovember 2007
ConditionsMigraine

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Migraine
Sponsor
Chengdu University of Traditional Chinese Medicine
Enrollment
480
Locations
1
Primary Endpoint
number of days with migraine
Status
Completed
Last Updated
15 years ago

Overview

Brief Summary

The purpose of the study is to testify whether acupuncture is effective for migraine, and provide evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."

Detailed Description

The purpose of the study is to testify whether acupuncture is effective for migraine, through treating migraine patients for a month, using different acupoints according to literatures of treating migraine with acupuncture, and try to provide clinical evidence for the hypothesis that"Acupuncture effect is based on meridians, and gathering of meridian Qi is the key point."

Registry
clinicaltrials.gov
Start Date
November 2007
End Date
September 2009
Last Updated
15 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Chengdu University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • Age of a subject is older than 18 and is younger than 65.(The subject is younger than 50 when he was ill for the first time.)
  • Consistent with the diagnostic criteria of Premonitory Migraine and Non- Premonitory Migraine.
  • Attacks of migraine are equal to or more than 2 times in the last three months.
  • With more than one year history of migraine
  • Informed consent is signed by a subject or his lineal relation.

Exclusion Criteria

  • With serious protopathy or disease of cardiovascular, liver, renal,gastrointestinal, hematological systems and so on.
  • Psychotic,patients with allergic constitution or easily getting infected or bleeding.
  • Patients have used drugs for preventing migraine in the last four weeks.
  • Pregnant women or women in lactation.

Outcomes

Primary Outcomes

number of days with migraine

Time Frame: 4 weeks

frequency of migraine attacks

Time Frame: 4 weeks

Secondary Outcomes

  • Migraine-Specific Quality-of-Life Questionnaire(a month)
  • Transcranial Doppler Sonography(a month)

Study Sites (1)

Loading locations...

Similar Trials